Kala Pharmaceuticals, Inc. (KALA)

Kala Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	48.48	50.9	70.5	94.18	77.26	85.45
Short-Term Investments	0	0	0	0	76.28	0
Cash & Cash Equivalents	48.48	50.9	70.5	94.18	153.54	85.45
Cash Growth	-23.82%	-27.80%	-25.15%	-38.66%	79.69%	-53.33%
Receivables	0	0	0	15.35	9.6	11.56
Inventory	0	0	0	18.22	11.45	8.43
Other Current Assets	1.61	1.98	15.45	-3.37	-3.21	0.05
Total Current Assets	50.09	52.87	85.94	124.37	171.38	105.48
Property, Plant & Equipment	2.66	2.78	0.42	4.02	31.02	32.48
Long-Term Investments	0	0	0.46	1.46	12.99	12.58
Other Long-Term Assets	0.29	0.3	0	9.58	6.22	3.78
Total Long-Term Assets	2.95	3.08	0.88	15.06	50.23	48.84
Total Assets	53.03	55.95	86.82	139.43	221.61	154.32
Accounts Payable	0.73	0.92	2.83	4.9	1.72	2.52
Deferred Revenue	0	1.08	0	0	0	0
Current Debt	6.34	0.33	5.01	0.71	1.53	1.33
Other Current Liabilities	4.81	6.02	17.84	31.81	18.97	20.93
Total Current Liabilities	11.88	8.35	25.69	37.42	22.23	24.77
Long-Term Debt	30.23	35.99	37.94	79.48	99.39	99.86
Other Long-Term Liabilities	4.27	4.11	4.22	5.72	0	0
Total Long-Term Liabilities	34.49	40.1	42.16	85.2	99.39	99.86
Total Liabilities	46.37	48.45	67.85	122.62	121.61	124.63
Total Debt	36.56	36.32	42.95	80.19	100.92	101.18
Debt Growth	9.90%	-15.43%	-46.44%	-20.54%	-0.26%	1.75%
Retained Earnings	-641.22	-629.41	-587.21	-542.39	-399.78	-295.46
Comprehensive Income	0	0	0	0	0	0
Shareholders' Equity	6.66	7.5	18.97	16.8	100	29.69
Net Cash / Debt	11.92	14.57	27.55	13.99	52.62	-15.74
Net Cash / Debt Growth	-60.76%	-47.10%	96.89%	-73.42%	-	-
Net Cash Per Share	4.24	5.99	18.11	10.63	50.24	-23.00
Working Capital	38.21	44.52	60.26	86.94	149.15	80.71
Book Value Per Share	2.37	3.09	12.48	12.76	95.46	43.40

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).